14.5501.82% ( -0.270 )
Delay Closed: Nov 16, 16:08:11Overview
CAM HSBIOTECH (3069)
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng...
- Open
- 14.820
- High
- 14.820
- Low
- 14.320
- Prev. Close
- 14.820
- Volume
- 5.33M
- Turnover
- 76.90M
- Avg Price
- 14.439
- Bid/Ask Ratio
- -79.49%
- Amplitude
- 3.37%
- 52wk High
- 17.040
- Volume Ratio
- 0.69
- Turnover Ratio
- 2.06%
- 52wk Low
- 11.690
- Dividend YieldTTM
- 0.34%
- DividendTTM
- 0.05
- NAV
- --
- NAV Date
- --
- Disc/Prem Rate
- --
- Total Issued
- 258.20M
- Assets
- 3.76B
- Min lot size
- 100
- Currency
- HKD
News
PUBT · Akeso Says FDA Complete Response Letter May Explain Unusual Share Price Moves
Market Movers · Akeso plunges 25% as FDA declines ivonescimab U.S. approval
PUBT · Akeso's Gumokimab Wins China Approval for Active Ankylosing Spondylitis
AASTOCKS News · UBS: AKESO Partner Receives FDA Complete Response Letter for ivonescimab Plus Chemotherapy BLA, Slightly Negative
PUBT · Innovent's Zybrivo Receives Positive CHMP Opinion for First-Line Lung Cancer Treatment
Tip Ranks · Innovent adds seven products to China’s 2026 NRDL
